The economic value of reducing mortality due to noncommunicable diseases and injuries
With population aging, national health systems face difficult trade-offs in allocating resources. The World Bank launched the Healthy Longevity Initiative to generate evidence for investing in policies that can improve healthy longevity and human capital. As part of this initiative, we quantified th...
Saved in:
Published in | Nature medicine Vol. 30; no. 11; pp. 3335 - 3344 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.11.2024
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | With population aging, national health systems face difficult trade-offs in allocating resources. The World Bank launched the Healthy Longevity Initiative to generate evidence for investing in policies that can improve healthy longevity and human capital. As part of this initiative, we quantified the economic value of reducing avoidable mortality from major noncommunicable diseases and injuries. We estimated avoidable mortality—the difference between lowest-achieved mortality frontiers and projected mortality trajectories—for each cause of death, for 2000, 2019 and 2050, and for geographic regions, with high-income countries, India and China considered separately; we applied economic values to these estimates. The economic value of reducing cardiovascular disease avoidable mortality would be large for both sexes in all regions, reaching 2–8% of annual income in 2019. For cancers, it would be 5–6% of annual income in high-income countries and China, and for injuries, it would be around 5% in sub-Saharan Africa and Latin America and the Caribbean. Despite the large uncertainty surrounding our estimates, we offer economic values for reducing avoidable mortality by cause and metrics comparable to annual incomes, which enable multisectoral priority setting and are relevant for high-level policy discussions around budget and resource allocations.
This study reports substantial economic value in annual income if mortality due to cardiovascular diseases, cancers and injuries is reduced. |
---|---|
AbstractList | With population aging, national health systems face difficult trade-offs in allocating resources. The World Bank launched the Healthy Longevity Initiative to generate evidence for investing in policies that can improve healthy longevity and human capital. As part of this initiative, we quantified the economic value of reducing avoidable mortality from major noncommunicable diseases and injuries. We estimated avoidable mortality-the difference between lowest-achieved mortality frontiers and projected mortality trajectories-for each cause of death, for 2000, 2019 and 2050, and for geographic regions, with high-income countries, India and China considered separately; we applied economic values to these estimates. The economic value of reducing cardiovascular disease avoidable mortality would be large for both sexes in all regions, reaching 2-8% of annual income in 2019. For cancers, it would be 5-6% of annual income in high-income countries and China, and for injuries, it would be around 5% in sub-Saharan Africa and Latin America and the Caribbean. Despite the large uncertainty surrounding our estimates, we offer economic values for reducing avoidable mortality by cause and metrics comparable to annual incomes, which enable multisectoral priority setting and are relevant for high-level policy discussions around budget and resource allocations. With population aging, national health systems face difficult trade-offs in allocating resources. The World Bank launched the Healthy Longevity Initiative to generate evidence for investing in policies that can improve healthy longevity and human capital. As part of this initiative, we quantified the economic value of reducing avoidable mortality from major noncommunicable diseases and injuries. We estimated avoidable mortality—the difference between lowest-achieved mortality frontiers and projected mortality trajectories—for each cause of death, for 2000, 2019 and 2050, and for geographic regions, with high-income countries, India and China considered separately; we applied economic values to these estimates. The economic value of reducing cardiovascular disease avoidable mortality would be large for both sexes in all regions, reaching 2–8% of annual income in 2019. For cancers, it would be 5–6% of annual income in high-income countries and China, and for injuries, it would be around 5% in sub-Saharan Africa and Latin America and the Caribbean. Despite the large uncertainty surrounding our estimates, we offer economic values for reducing avoidable mortality by cause and metrics comparable to annual incomes, which enable multisectoral priority setting and are relevant for high-level policy discussions around budget and resource allocations. This study reports substantial economic value in annual income if mortality due to cardiovascular diseases, cancers and injuries is reduced. With population aging, national health systems face difficult trade-offs in allocating resources. The World Bank launched the Healthy Longevity Initiative to generate evidence for investing in policies that can improve healthy longevity and human capital. As part of this initiative, we quantified the economic value of reducing avoidable mortality from major noncommunicable diseases and injuries. We estimated avoidable mortality—the difference between lowest-achieved mortality frontiers and projected mortality trajectories—for each cause of death, for 2000, 2019 and 2050, and for geographic regions, with high-income countries, India and China considered separately; we applied economic values to these estimates. The economic value of reducing cardiovascular disease avoidable mortality would be large for both sexes in all regions, reaching 2–8% of annual income in 2019. For cancers, it would be 5–6% of annual income in high-income countries and China, and for injuries, it would be around 5% in sub-Saharan Africa and Latin America and the Caribbean. Despite the large uncertainty surrounding our estimates, we offer economic values for reducing avoidable mortality by cause and metrics comparable to annual incomes, which enable multisectoral priority setting and are relevant for high-level policy discussions around budget and resource allocations.This study reports substantial economic value in annual income if mortality due to cardiovascular diseases, cancers and injuries is reduced. With population aging, national health systems face difficult trade-offs in allocating resources. The World Bank launched the Healthy Longevity Initiative to generate evidence for investing in policies that can improve healthy longevity and human capital. As part of this initiative, we quantified the economic value of reducing avoidable mortality from major noncommunicable diseases and injuries. We estimated avoidable mortality-the difference between lowest-achieved mortality frontiers and projected mortality trajectories-for each cause of death, for 2000, 2019 and 2050, and for geographic regions, with high-income countries, India and China considered separately; we applied economic values to these estimates. The economic value of reducing cardiovascular disease avoidable mortality would be large for both sexes in all regions, reaching 2-8% of annual income in 2019. For cancers, it would be 5-6% of annual income in high-income countries and China, and for injuries, it would be around 5% in sub-Saharan Africa and Latin America and the Caribbean. Despite the large uncertainty surrounding our estimates, we offer economic values for reducing avoidable mortality by cause and metrics comparable to annual incomes, which enable multisectoral priority setting and are relevant for high-level policy discussions around budget and resource allocations.With population aging, national health systems face difficult trade-offs in allocating resources. The World Bank launched the Healthy Longevity Initiative to generate evidence for investing in policies that can improve healthy longevity and human capital. As part of this initiative, we quantified the economic value of reducing avoidable mortality from major noncommunicable diseases and injuries. We estimated avoidable mortality-the difference between lowest-achieved mortality frontiers and projected mortality trajectories-for each cause of death, for 2000, 2019 and 2050, and for geographic regions, with high-income countries, India and China considered separately; we applied economic values to these estimates. The economic value of reducing cardiovascular disease avoidable mortality would be large for both sexes in all regions, reaching 2-8% of annual income in 2019. For cancers, it would be 5-6% of annual income in high-income countries and China, and for injuries, it would be around 5% in sub-Saharan Africa and Latin America and the Caribbean. Despite the large uncertainty surrounding our estimates, we offer economic values for reducing avoidable mortality by cause and metrics comparable to annual incomes, which enable multisectoral priority setting and are relevant for high-level policy discussions around budget and resource allocations. |
Author | Verguet, Stéphane Stevens, Gretchen A. Chang, Angela Y. Bolongaita, Sarah Cardoso, Diego S. |
Author_xml | – sequence: 1 givenname: Stéphane orcidid: 0000-0003-4128-0849 surname: Verguet fullname: Verguet, Stéphane email: verguet@hsph.harvard.edu organization: Department of Global Health and Population, Harvard T.H. Chan School of Public Health – sequence: 2 givenname: Sarah orcidid: 0000-0003-0886-0454 surname: Bolongaita fullname: Bolongaita, Sarah organization: Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Bergen Centre for Ethics and Priority Setting, Department of Global Public Health and Primary Care, University of Bergen – sequence: 3 givenname: Angela Y. orcidid: 0000-0003-3947-3588 surname: Chang fullname: Chang, Angela Y. organization: Danish Institute for Advanced Study, University of Southern Denmark, Interdisciplinary Centre on Population Dynamics (CPop), University of Southern Denmark – sequence: 4 givenname: Diego S. orcidid: 0000-0001-6781-1025 surname: Cardoso fullname: Cardoso, Diego S. organization: Department of Agricultural and Consumer Economics, University of Illinois Urbana-Champaign – sequence: 5 givenname: Gretchen A. surname: Stevens fullname: Stevens, Gretchen A. organization: Independent researcher |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39333314$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1PHSEUhkljU7_6B1w0JN10M5XvgZVpTLVNTNxo0h3hwpkrNzOgMGPivy_tVWtdyAbC-5yXc3j30U7KCRA6ouQrJVwfV0GloR1hoiOcCd2Jd2iPSqE62pNfO-1Met1pI9Uu2q91QwjhRJoPaJcb3hYVe-j66gYw-JzyFD2-d-MCOA-4QFh8TGs85TK7Mc4PODRlzrj14PM0LSl6txoBh1jBVajYpYBj2iwlQj1E7wc3Vvj4uB-g67PvV6c_uovL85-n3y46z6WaO9MTPmhKBVXEuV5QppT2Ug7twgjHggpcSR648YI7JVaOKdYPoafCgXGaH6CTre_tspogeEhzcaO9LXFy5cFmF-3_Soo3dp3vLaVSCaJlc_jy6FDy3QJ1tlOsHsbRJchLtZy2T2S6N6yhn1-hm7yU1OZrFNNCMSH7RrEt5UuutcDw3A0l9k9sdhubbbHZv7FZ0Yo-vZzjueQppwbwLVCblNZQ_r39hu1v5IikxA |
Cites_doi | 10.1007/s10654-020-00642-3 10.1016/S0140-6736(09)61460-4 10.1017/bca.2018.26 10.1371/journal.pmed.0030442 10.1007/s11166-020-09338-1 10.1016/S0140-6736(16)32381-9 10.1186/s12916-021-02029-x 10.1016/j.jhealeco.2023.102847 10.1007/s11357-020-00296-9 10.1056/NEJMsa053935 10.1023/A:1025598106257 10.1016/j.econlet.2024.111673 10.1016/S0140-6736(14)60569-9 10.1016/j.jeoa.2018.09.002 10.1016/S0140-6736(21)02347-3 10.1038/s41586-018-0457-8 10.1017/bca.2017.12 10.1215/00703370-9938662 10.1016/S0140-6736(13)62105-4 10.1016/S0140-6736(20)30925-9 10.1108/JHR-09-2020-0406 10.1038/s41591-024-03253-7 10.1017/9781108691734 10.1016/j.eclinm.2022.101675 10.1073/pnas.2019536118 10.1001/jamaoncol.2022.7826 10.1007/s10433-022-00699-x 10.1111/risa.13427 10.1017/bca.2023.25 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 2024 |
Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 2024 |
DBID | C6C CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QG 7QL 7QP 7QR 7T5 7TK 7TM 7TO 7U7 7U9 8FD C1K FR3 H94 K9. M7N P64 RC3 7X8 5PM |
DOI | 10.1038/s41591-024-03248-4 |
DatabaseName | Springer Nature OA Free Journals Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts Technology Research Database Toxicology Abstracts Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management Genetics Abstracts Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE Virology and AIDS Abstracts MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen website url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology Economics |
EISSN | 1546-170X |
EndPage | 3344 |
ExternalDocumentID | 10_1038_s41591_024_03248_4 39333314 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: World Bank Group (World Bank) funderid: https://doi.org/10.13039/100004421 – fundername: World Bank’s Healthy Longevity Initiative |
GroupedDBID | --- .-4 .55 .GJ 0R~ 123 1CY 29M 2FS 36B 39C 3O- 3V. 4.4 53G 5BI 5M7 5RE 5S5 70F 7X7 85S 88A 88E 88I 8AO 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AAEEF AARCD AAYOK AAYZH AAZLF ABAWZ ABCQX ABDBF ABDPE ABEFU ABJNI ABLJU ABOCM ABUWG ACBWK ACGFO ACGFS ACGOD ACIWK ACMJI ACPRK ADBBV ADFRT AENEX AFBBN AFKRA AFRAH AFSHS AGAYW AGCDD AGEZK AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH ARMCB ASPBG AVWKF AXYYD AZFZN AZQEC B0M BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI C6C CCPQU CS3 DB5 DU5 DWQXO EAD EAP EBC EBD EBS EE. EJD EMB EMK EMOBN EPL ESX EXGXG F5P FEDTE FQGFK FSGXE FYUFA GNUQQ GUQSH GX1 HCIFZ HMCUK HVGLF HZ~ IAO IEA IH2 IHR IHW INH INR IOF IOV ISR ITC J5H L7B LGEZI LK8 LOTEE M0L M1P M2O M2P M7P MK0 N9A NADUK NNMJJ NXXTH O9- ODYON P2P PQQKQ PROAC PSQYO Q2X RIG RNS RNT RNTTT RVV SHXYY SIXXV SJN SNYQT SV3 TAE TAOOD TBHMF TDRGL TSG TUS UKHRP UQL X7M XJT YHZ ZGI ~8M CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QG 7QL 7QP 7QR 7T5 7TK 7TM 7TO 7U7 7U9 8FD C1K FR3 H94 K9. M7N P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c356t-9703f8114160aa7412668c55f41694a2d6d3653d39c43a64ba2627fd714ae9a83 |
IEDL.DBID | C6C |
ISSN | 1078-8956 1546-170X |
IngestDate | Mon Nov 18 05:18:17 EST 2024 Thu Dec 05 20:12:05 EST 2024 Sat Nov 16 05:05:07 EST 2024 Fri Dec 06 06:42:17 EST 2024 Thu Nov 28 21:47:03 EST 2024 Fri Nov 15 01:26:34 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c356t-9703f8114160aa7412668c55f41694a2d6d3653d39c43a64ba2627fd714ae9a83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-4128-0849 0000-0003-3947-3588 0000-0001-6781-1025 0000-0003-0886-0454 |
OpenAccessLink | https://doi.org/10.1038/s41591-024-03248-4 |
PMID | 39333314 |
PQID | 3128462457 |
PQPubID | 33975 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11564085 proquest_miscellaneous_3110728792 proquest_journals_3128462457 crossref_primary_10_1038_s41591_024_03248_4 pubmed_primary_39333314 springer_journals_10_1038_s41591_024_03248_4 |
PublicationCentury | 2000 |
PublicationDate | 2024-Nov |
PublicationDateYYYYMMDD | 2024-11-01 |
PublicationDate_xml | – month: 11 year: 2024 text: 2024-Nov |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationTitle | Nature medicine |
PublicationTitleAbbrev | Nat Med |
PublicationTitleAlternate | Nat Med |
PublicationYear | 2024 |
Publisher | Nature Publishing Group US Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group US – name: Nature Publishing Group |
References | World Development Indicators. World Bankhttps://datatopics.worldbank.org/world-development-indicators/ (2022). Jamison, D. T., Jha, P., Laxminarayan, R. & Ord, T. in Global Problems, Smart Solutions: Costs and Benefits (ed. Lomborg, B.) Ch. 7 (Cambridge Univ. Press, 2013). World Development Indicators. World Bankhttps://datatopics.worldbank.org/world-development-indicators/ (2024). MathersCDStevensGABoermaTWhiteRATobiasMICauses of international increases in older age life expectancyLancet201538554054810.1016/S0140-6736(14)60569-925468166 BloomDEThe economic burden of chronic diseases: estimates and projections for China, Japan, and South KoreaJ. Econ. Ageing20201710.1016/j.jeoa.2018.09.002 Texeira da SilvaJATsigarisPEstimating worldwide costs of premature mortalities caused by COVID-19J. Health Res.20213535335810.1108/JHR-09-2020-0406 KontisVFuture life expectancy in 35 industrialised countries: projections with a Bayesian model ensembleLancet20173891323133510.1016/S0140-6736(16)32381-9282364645387671 WatkinsDAhmedSPickersgillSBest investments in chronic, non-communicable disease prevention and control in low- and lower-middle-income countriesJ. Benefit Cost Anal.20231425527110.1017/bca.2023.25 ChristensenKDoblhammerGRauRVaupelJWAgeing populations: the challenges aheadLancet20093741196120810.1016/S0140-6736(09)61460-4198010982810516 NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies and 104 million participants. Lancet398, 957–980 (2021). Healthy Longevity Initiative (Center for Global Health Research, 2024); https://www.cghr.org/projects/healthy-longevity-initiative Da CostaSO’DonnellOVan GestelRDistributionally sensitive measurement and valuation of population healthJ. Health Econ.20249310284710.1016/j.jhealeco.2023.10284738154202 Adler, M. D. & Norheim, O. F. Prioritarianism in Practice (Cambridge Univ. Press, 2022). Lomborg, B. Best Things First (Cambridge Univ. Press, 2022). GBD 2019. Institute for Health Metrics and Evaluation (IHME)https://vizhub.healthdata.org/gbd-compare/ (2022). Global health estimates 2019. World Health Organizationhttps://www.who.int/data/global-health-estimates (2020). MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med.20063e44210.1371/journal.pmed.0030442171320521664601 PayneCFExpansion, compression, neither, both? Divergent patterns in healthy, disability-free, and morbidity-free life expectancy across US birth cohorts, 1998–2016Demography20225994997310.1215/00703370-993866235522071 JamisonDTGlobal health 2035: a world converging within a generationLancet20133821898195510.1016/S0140-6736(13)62105-424309475 SpasovaSBaetenRVanherckeBChallenges in long-term care in EuropeEurohealth Obs.201824712 ViscusiKAldyJEThe value of a statistical life: a critical review of market estimates throughout the worldJ. Risk Uncertain.20032757610.1023/A:1025598106257 KhadkaAVerguetSThe economic value of changing mortality risk in low- and middle-income countries: a systematic breakdown by cause of deathBMC Med.20211910.1186/s12916-021-02029-x342664208282406 United Nations Department of Economic and Social Affairs World population prospects 2022. United Nationshttps://population.un.org/wpp/ (2022). RobinsonLAHammittJKO’KeeffeLValuing mortality risk reductions in global benefit–cost analysisJ. Benefit Cost. Anal.201910155010.1017/bca.2018.26329686167473065 MohantySKMorbidity compression or expansion? A temporal analysis of the age at onset of non-communicable diseases in IndiaGeroscience20214340942210.1007/s11357-020-00296-9334100918050145 TynkkynnenL-KHealth system reforms and the needs of the ageing population—an analysis of recent policy paths and reform trends in Finland and SwedenEur. J. Ageing20221922123210.1007/s10433-022-00699-x PartridgeLDeelenJSlagboomPEFacing up to the global challenges of ageingNature201856145561:CAS:528:DC%2BC1cXhs1OmsrvL10.1038/s41586-018-0457-830185958 GBD 2019 Diseases and Injuries Collaborators Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet396, 1204–1222 (2020). ViscusiKMastermanCJIncome elasticity and the global value of a statistical lifeJ. Benefit Cost Anal.2017822625010.1017/bca.2017.12 NCD Countdown 2030 collaborators NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low- and middle-income countries. Lancet399, 1266–1278 (2022). SeamanRRethinking morbidity compressionEur. J. Epidemiol.20203538138810.1007/s10654-020-00642-3324180237250949 ChenSEstimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050JAMA Oncol.2023946547210.1001/jamaoncol.2022.7826368211079951101 VaupelJWVillavicencioFBergeron-BoucherM-PDemographic perspectives on the rise of longevityProc. Natl Acad. Sci. USA20211181:CAS:528:DC%2BB3MXls12qt78%3D10.1073/pnas.2019536118335711377936303 WHO Methods and Data Sources for Country-Level Causes of Death 2000–2019 (Word Health Organization, 2020); https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_cod_methods.pdf?sfvrsn=37bcfacc_5 AriasDSaxenaSVerguetSQuantifying the global burden of mental disorders and their economic valueEClinicalMedicine20225410167510.1016/j.eclinm.2022.101675361931719526145 HammittJKValuing mortality risk in the time of COVID-19J. Risk Uncertain.20206112915410.1007/s11166-020-09338-1331999407656098 FordESExplaining the decrease in US deaths from coronary disease, 1980–2000N. Engl. J. Med.2007356238823981:CAS:528:DC%2BD2sXmt1Wnsbs%3D10.1056/NEJMsa05393517554120 Jha, P., Hum, R., Nugent, R., Verguet, S. & Bloom, D. in Global Problems, Smart Solutions: Costs and Benefits (ed. Lomborg, B.) Ch. 3 (Cambridge Univ. Press, 2013). Bloom, D. E. et al. The Global Economic Burden of Non-Communicable Diseases (World Economic Forum, 2011); http://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf HammittJKMorfeldPTuomistoJTErrenTCPremature deaths, statistical lives, and years of life lost: identification, quantification, and valuation of mortality risksRisk Anal.20204067469510.1111/risa.1342731820829 CardosoDSDahisRCalculating the economic value of non-marginal mortality risk reductionsEcon. Lett.202423711167310.1016/j.econlet.2024.111673 Chang, A. Y., Stevens, G. A., Cardoso, D. S., Cao, B. & Jamison D. T. The economic value of reducing avoidable mortality. Nat. Med.https://doi.org/10.1038/s41591-024-03253-7 (2024). Jha, P. et al. Unlocking the Power of Healthy Longevity: Demographic Change, Noncommunicable Diseases, and Human Capital (World Bank, 2024). Copenhagen Consensus Center https://www.copenhagenconsensus.com/ (2023). Robinson, L. A. et al. Reference Case Guidelines for Benefit–Cost Analysis in Global Health and Development (Harvard T.H. Chan School of Public Health, 2019); https://www.hsph.harvard.edu/bcaguidelines/wp-content/uploads/sites/2447/2019/05/BCA-Guidelines-May-2019.pdf 3248_CR22 3248_CR42 3248_CR25 L Partridge (3248_CR7) 2018; 561 3248_CR26 K Viscusi (3248_CR44) 2017; 8 3248_CR23 D Watkins (3248_CR41) 2023; 14 3248_CR45 SK Mohanty (3248_CR5) 2021; 43 3248_CR40 DS Cardoso (3248_CR39) 2024; 237 V Kontis (3248_CR37) 2017; 389 JK Hammitt (3248_CR32) 2020; 61 S Chen (3248_CR30) 2023; 9 S Spasova (3248_CR8) 2018; 24 R Seaman (3248_CR6) 2020; 35 DE Bloom (3248_CR29) 2020; 17 3248_CR1 D Arias (3248_CR31) 2022; 54 JK Hammitt (3248_CR34) 2020; 40 3248_CR27 CF Payne (3248_CR4) 2022; 59 3248_CR28 DT Jamison (3248_CR20) 2013; 382 JW Vaupel (3248_CR2) 2021; 118 3248_CR10 K Viscusi (3248_CR38) 2003; 27 3248_CR11 3248_CR14 3248_CR12 3248_CR13 LA Robinson (3248_CR15) 2019; 10 K Christensen (3248_CR3) 2009; 374 A Khadka (3248_CR21) 2021; 19 S Da Costa (3248_CR35) 2024; 93 JA Texeira da Silva (3248_CR33) 2021; 35 ES Ford (3248_CR24) 2007; 356 CD Mathers (3248_CR36) 2006; 3 3248_CR18 L-K Tynkkynnen (3248_CR9) 2022; 19 3248_CR19 3248_CR16 3248_CR17 CD Mathers (3248_CR43) 2015; 385 |
References_xml | – ident: 3248_CR18 – volume: 35 start-page: 381 year: 2020 ident: 3248_CR6 publication-title: Eur. J. Epidemiol. doi: 10.1007/s10654-020-00642-3 contributor: fullname: R Seaman – ident: 3248_CR45 – volume: 374 start-page: 1196 year: 2009 ident: 3248_CR3 publication-title: Lancet doi: 10.1016/S0140-6736(09)61460-4 contributor: fullname: K Christensen – volume: 10 start-page: 15 year: 2019 ident: 3248_CR15 publication-title: J. Benefit Cost. Anal. doi: 10.1017/bca.2018.26 contributor: fullname: LA Robinson – ident: 3248_CR16 – volume: 3 start-page: e442 year: 2006 ident: 3248_CR36 publication-title: PLoS Med. doi: 10.1371/journal.pmed.0030442 contributor: fullname: CD Mathers – ident: 3248_CR14 – volume: 61 start-page: 129 year: 2020 ident: 3248_CR32 publication-title: J. Risk Uncertain. doi: 10.1007/s11166-020-09338-1 contributor: fullname: JK Hammitt – volume: 389 start-page: 1323 year: 2017 ident: 3248_CR37 publication-title: Lancet doi: 10.1016/S0140-6736(16)32381-9 contributor: fullname: V Kontis – volume: 19 year: 2021 ident: 3248_CR21 publication-title: BMC Med. doi: 10.1186/s12916-021-02029-x contributor: fullname: A Khadka – volume: 93 start-page: 102847 year: 2024 ident: 3248_CR35 publication-title: J. Health Econ. doi: 10.1016/j.jhealeco.2023.102847 contributor: fullname: S Da Costa – volume: 43 start-page: 409 year: 2021 ident: 3248_CR5 publication-title: Geroscience doi: 10.1007/s11357-020-00296-9 contributor: fullname: SK Mohanty – ident: 3248_CR28 – ident: 3248_CR11 – volume: 356 start-page: 2388 year: 2007 ident: 3248_CR24 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMsa053935 contributor: fullname: ES Ford – ident: 3248_CR13 – volume: 27 start-page: 5 year: 2003 ident: 3248_CR38 publication-title: J. Risk Uncertain. doi: 10.1023/A:1025598106257 contributor: fullname: K Viscusi – volume: 237 start-page: 111673 year: 2024 ident: 3248_CR39 publication-title: Econ. Lett. doi: 10.1016/j.econlet.2024.111673 contributor: fullname: DS Cardoso – volume: 385 start-page: 540 year: 2015 ident: 3248_CR43 publication-title: Lancet doi: 10.1016/S0140-6736(14)60569-9 contributor: fullname: CD Mathers – ident: 3248_CR1 – volume: 17 year: 2020 ident: 3248_CR29 publication-title: J. Econ. Ageing doi: 10.1016/j.jeoa.2018.09.002 contributor: fullname: DE Bloom – ident: 3248_CR19 – ident: 3248_CR26 doi: 10.1016/S0140-6736(21)02347-3 – volume: 561 start-page: 45 year: 2018 ident: 3248_CR7 publication-title: Nature doi: 10.1038/s41586-018-0457-8 contributor: fullname: L Partridge – ident: 3248_CR17 – ident: 3248_CR42 – ident: 3248_CR23 – volume: 8 start-page: 226 year: 2017 ident: 3248_CR44 publication-title: J. Benefit Cost Anal. doi: 10.1017/bca.2017.12 contributor: fullname: K Viscusi – volume: 59 start-page: 949 year: 2022 ident: 3248_CR4 publication-title: Demography doi: 10.1215/00703370-9938662 contributor: fullname: CF Payne – volume: 382 start-page: 1898 year: 2013 ident: 3248_CR20 publication-title: Lancet doi: 10.1016/S0140-6736(13)62105-4 contributor: fullname: DT Jamison – ident: 3248_CR25 doi: 10.1016/S0140-6736(20)30925-9 – volume: 35 start-page: 353 year: 2021 ident: 3248_CR33 publication-title: J. Health Res. doi: 10.1108/JHR-09-2020-0406 contributor: fullname: JA Texeira da Silva – ident: 3248_CR27 – ident: 3248_CR22 doi: 10.1038/s41591-024-03253-7 – ident: 3248_CR40 doi: 10.1017/9781108691734 – ident: 3248_CR10 – volume: 54 start-page: 101675 year: 2022 ident: 3248_CR31 publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2022.101675 contributor: fullname: D Arias – ident: 3248_CR12 – volume: 24 start-page: 7 year: 2018 ident: 3248_CR8 publication-title: Eurohealth Obs. contributor: fullname: S Spasova – volume: 118 year: 2021 ident: 3248_CR2 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.2019536118 contributor: fullname: JW Vaupel – volume: 9 start-page: 465 year: 2023 ident: 3248_CR30 publication-title: JAMA Oncol. doi: 10.1001/jamaoncol.2022.7826 contributor: fullname: S Chen – volume: 19 start-page: 221 year: 2022 ident: 3248_CR9 publication-title: Eur. J. Ageing doi: 10.1007/s10433-022-00699-x contributor: fullname: L-K Tynkkynnen – volume: 40 start-page: 674 year: 2020 ident: 3248_CR34 publication-title: Risk Anal. doi: 10.1111/risa.13427 contributor: fullname: JK Hammitt – volume: 14 start-page: 255 year: 2023 ident: 3248_CR41 publication-title: J. Benefit Cost Anal. doi: 10.1017/bca.2023.25 contributor: fullname: D Watkins |
SSID | ssj0003059 |
Score | 2.5275269 |
Snippet | With population aging, national health systems face difficult trade-offs in allocating resources. The World Bank launched the Healthy Longevity Initiative to... |
SourceID | pubmedcentral proquest crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 3335 |
SubjectTerms | 692/700 692/700/3934 Biomedical and Life Sciences Biomedicine Cancer Cancer Research Cardiovascular diseases Cardiovascular Diseases - economics Cardiovascular Diseases - mortality Cause of Death Economics Estimates Female Global Health - economics Human capital Humans Income Industrialized nations Infectious Diseases Injuries Injury prevention Longevity Male Metabolic Diseases Molecular Medicine Mortality Neoplasms - economics Neoplasms - mortality Neurosciences Noncommunicable Diseases - economics Noncommunicable Diseases - mortality Resource allocation Wounds and Injuries - economics Wounds and Injuries - mortality |
Title | The economic value of reducing mortality due to noncommunicable diseases and injuries |
URI | https://link.springer.com/article/10.1038/s41591-024-03248-4 https://www.ncbi.nlm.nih.gov/pubmed/39333314 https://www.proquest.com/docview/3128462457 https://www.proquest.com/docview/3110728792 https://pubmed.ncbi.nlm.nih.gov/PMC11564085 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dT9swED8xKqa9IL4GYQx50t7AWmM7jv1Iq1UIqTxRibfo7Dii00hRWx7233NO0qKO7YE8xtY5uTv7fufznQG-6-D6SGseF96Rg4LecUxRc-91JS3maDHuQ45v9fVE3dxn912ZnJgLsxG_l-bHggxMPJsjFO-T7TdcfYAe2eA8avNQD9erLumtbc8XGm4I9HcJMv-msWmE3iDLtwck_4qSNsZntAe7HWpkV62Y92Er1Aew094j-ecAPo67CPkhTEjuLHTZxiyW8g5sVrF5rNBKpNljA7cJerOSWpYzRu6_XyWJuN-BdRGbBcO6ZNP6V7zSbnEEk9HPu-E1765O4F5mesktTeTKkK-T6j4ioQayw8ZnWUUvrEJR6lLqTJbSeiVRK4dCi7wq81RhsGjkZ9im8cMJsL7KfVaW0olKKe-cwyANEUDhjSAXN4GLFS-Lp7ZCRtFEtqUpWs4XxPmi4XyhEjhbsbvoZsuikNFIaqGyPIFv62bS8xi8wDrMnmMfEi25d1YkcNxKZz2ctJKelIibDbmtO8Qa2pst9fShqaWdxmI5BDsTuFyJ-PW7_v8bp-_r_gU-iah-TQ7jGWwv58_hK4GZpTuH3tVoMLg9b7T5BSNd7BQ |
link.rule.ids | 230,314,780,784,885,27924,27925,41120,42189,51576 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dT9wwDLcGE2wv08bXujHIpL2NiGuSpsnjdBq6AccTJ_EWOWkqmEYPccfD_vs5be-mg_GwPjaR09pO_HMcOwBfdPQDpDWPi-DJQcHgOeaoeQi6lhZLtJj2IccXejRRp1fFVV8mJ-XCrMTvpTmekYFJZ3OE4gOy_YarNXipyC4lDR7q4XLVJb213flCww2B_j5B5t80Vo3QE2T59IDkoyhpa3xO3sKbHjWyb52Y38GL2GzBRneP5O8t2Bz3EfJtmJDcWeyzjVkq5R3ZtGb3qUIrkWa3Ldwm6M0qaplPGbn_YZEk4n9F1kdsZgybit00P9OVdrMdmJx8vxyOeH91Ag-y0HNuaSLXhnydXA8QCTWQHTahKGp6YRWKSldSF7KSNiiJWnkUWpR1VeYKo0Ujd2Gdxo_vgQ1UGYqqkl7USgXvPUZpiACKYAS5uBl8XfDS3XUVMlwb2ZbGdZx3xHnXct6pDPYX7Hb9bJk5mYykFqooM_i8bCY9T8ELbOL0IfUh0ZJ7Z0UGe510lsNJK-nJibhZkduyQ6qhvdrS3Fy3tbTzVCyHYGcGRwsR__2u53_jw_91P4RXo8vxuTv_cXH2EV6LpIptPuM-rM_vH-InAjZzf9Bq9B_pbe2C |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BERUXBOUVKGAkbmB1YzuOfUQLq_JoxYGVerPGj6hFkK266YF_zziPhaVwIMfYcpKZseebzAvgpU5-hnTmcRE8GSgYPMcSNQ9BN9JijRbzf8ijY324VB9OqpPfsvj7aPfJJTnkNOQqTW13cB6bMUncHKxJ7eSIHaH4jBCB4eo63FAEHXLzhrmeb85ikmY7RB0absgUGNNm_r7Gtmq6gjevhk3-4TvtVdLiDtwesSR7MzD_LlxL7R7cHLpL_tiD3aPRb34PliQNLI05yCwX-E5s1bCLXLeVlmbfexBOgJxFGulWrF21YUod8d8SG_04a4ZtZGft19zobn0flot3X-aHfGyowIOsdMctbe_GkAVU6hkiYQnSziZUVUM3rEIRdZS6klHaoCRq5VFoUTexLhUmi0Y-gB16fnoEbKbqUMUovWiUCt57TNLQAiiCEWT4FvBqoqU7H-pmuN7fLY0bKO-I8q6nvFMF7E_kduMeWjuZVacWqqoLeLEZJunPLg1s0-oyzyHWktFnRQEPB-5sHietpKukxc0W3zYTcmXt7ZH27LSvsF3mEjoERgt4PbH413v9-zMe_9_057D7-e3CfXp__PEJ3BJZEvskx33Y6S4u01NCO51_1gv0T5lm9cA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+economic+value+of+reducing+mortality+due+to+noncommunicable+diseases+and+injuries&rft.jtitle=Nature+medicine&rft.au=Verguet%2C+St%C3%A9phane&rft.au=Bolongaita%2C+Sarah&rft.au=Chang%2C+Angela+Y&rft.au=Cardoso%2C+Diego+S&rft.date=2024-11-01&rft.pub=Nature+Publishing+Group&rft.issn=1078-8956&rft.eissn=1546-170X&rft.volume=30&rft.issue=11&rft.spage=3335&rft.epage=3344&rft_id=info:doi/10.1038%2Fs41591-024-03248-4&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1078-8956&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1078-8956&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1078-8956&client=summon |